Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
From the article
You might also wanna read
One-Time Gene Therapy Restores Vision in 6-Year-Old with Rare Congenital Blindness
A 6-year-old girl named Saffie Sandford from Stevenage, UK, has had her vision saved through a one-time gene therapy for Leber's Congenital
goodnewsnetwork.org·18d ago
Scripps Research identifies erucamide as key molecule in retinal protection against degenerative disease
Researchers at Scripps Research have identified that the naturally occurring molecule erucamide plays a key role in the eye's protective res
Life Biosciences' ER-100 gene therapy aims to restore vision by rejuvenating retinal neurons through epigenetic reprogramming
Life Biosciences has developed ER-100, a first-ever experimental gene therapy that aims to restore vision by rejuvenating damaged retinal ne
interestingengineering.com·1mo ago
Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss
Life Biosciences has dosed the first human patient with ER-100, a cellular rejuvenation therapy designed to reverse age-related sight loss b
wired.com·24d ago
Plasma proteomic signatures enable risk prediction of early retinal neurodegeneration in type 2 diabetes
This multi-cohort prospective observational study by Wei Wang and colleagues investigates circulating plasma protein signatures associated w
plos.io·1mo ago
TAAP-2: Advancing Research on Age-Related Macular Degeneration in Asia
The article discusses the Translational Asian Age-related Macular Degeneration Programme Phase 2 (TAAP-2), a research initiative addressing
scientia.global·16d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.